Patents and Trademarks: empirical evidence on 'evergreening' from Australia
Evergreening is a strategy employed by pharmaceutical companies to extend patent protection around their branded medicines beyond 25 years. It involves claiming modifications to the original active pharmaceutical ingredient (API) as separate "inventions" to extend the period during which pharmaceutically equivalent products are denied market entry. Evergreening refers only to patents taken out by the company owning the original API. Similar improvement/modification patents taken out by other...[Show more]
|Collections||ANU Research Publications|
|Source:||Asia-Pacific Journal of Accounting & Economics (APJAE)|
|Moir & Palombi Patents and trademarks 2013.pdf||980.39 kB||Adobe PDF|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.